What is the clinical significance of a benign soft tissue mass and a stable 3 mm nodule in the fat anterior to the psoas muscle in a patient with a history of partial nephrectomy for chromophobe renal cell carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The 3 mm nodule in the fat anterior to the psoas muscle is likely a benign post-surgical change and does not require immediate intervention, given its stability and the patient's history of partial nephrectomy for chromophobe renal cell carcinoma. The fact that the nodule has remained stable suggests that it is not aggressive and may not require frequent follow-up imaging. According to the guidelines for management of incidental pulmonary nodules detected on CT images, a nodule of this size would not typically warrant immediate concern, as the risk of malignancy is low 1.

Key Considerations

  • The patient's history of partial nephrectomy for chromophobe renal cell carcinoma is important to consider, as the risk of recurrence is low for small, T1A stage tumors with no sarcomatoid features or necrosis 1.
  • The nodule's stability over time suggests that it is likely a benign post-surgical change, rather than a recurrent tumor.
  • The American Society of Clinical Oncology clinical practice guideline for management of small renal masses recommends a multidisciplinary assessment of the patient's overall medical condition and functional status, including consideration of comorbidities and performance status 1.

Recommendations

  • Continued surveillance imaging for the 3 mm nodule in the fat anterior to the psoas muscle, with follow-up scans at 6-12 month intervals for the first few years, then annually for at least 5 years.
  • Blood work to monitor kidney function is also recommended, given the patient's history of partial nephrectomy.
  • If the nodule remains stable in size and appearance on subsequent scans, this further supports its benign nature and suggests that no immediate intervention is necessary.

From the Research

Clinical Significance of Benign Soft Tissue Mass and Stable 3 mm Nodule

  • The clinical significance of a benign soft tissue mass and a stable 3 mm nodule in the fat anterior to the psoas muscle in a patient with a history of partial nephrectomy for chromophobe renal cell carcinoma is not directly discussed in the provided studies 2, 3, 4, 5, 6.
  • However, the studies discuss the importance of surveillance imaging in detecting recurrence of various cancers, such as oral squamous cell carcinoma 2, papillary thyroid microcarcinoma 3, and incidental pulmonary nodules 5.
  • The studies also highlight the need for individualized approaches to surveillance imaging, taking into account factors such as patient history, tumor characteristics, and clinical presentation 6.
  • In the context of incidental findings, such as the benign soft tissue mass and stable 3 mm nodule, it is essential to consider the potential for false positives and the need for careful evaluation to avoid unnecessary investigations and interventions 4, 5.

Surveillance Imaging Strategies

  • Surveillance imaging strategies are crucial in detecting recurrence and monitoring disease progression in patients with a history of cancer 2, 3, 5, 6.
  • The choice of imaging modality, frequency, and duration of surveillance should be individualized based on patient-specific factors, such as tumor type, stage, and treatment history 6.
  • The studies emphasize the importance of evidence-based guidelines and consensus recommendations to standardize surveillance imaging strategies and improve patient outcomes 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Incidental pulmonary nodules - current guidelines and management.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2024

Research

Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.